VIP Protocol
Dosing & Research
Last Updated: April 22, 2026
Bronchodilation and vasodilation research, Immune modulation, Gut-lung axis studies, Neuropeptide signaling
Half-Life
Very Short In Circulation, Often Only Minutes
Administration
• Intranasal
• Subcutaneous
Frequency
Up to 2x daily (SubQ); or split 2-3 doses daily (intranasal)
How It Works
- Bronchodilation and vasodilation research
- Immune modulation
- Gut-lung axis studies
- Neuropeptide signaling
Dosing Structure
Dose
50 mcg
Frequency
Up to 2x daily (SubQ); or split 2-3 doses daily (intranasal)
Notes
SubQ: 25-100mcg per injection up to twice per day. Intranasal: 200-600mcg per day split into 2-3 doses. Specific cycling guidance was absent from publications. Recommend reassessing every 8 weeks and taking periodic breaks out of caution. May use continuously under medical supervision.
Example Protocols
Dose: 50 mcg
Frequency: Up to 2x daily (SubQ); or split 2-3 doses daily (intranasal)
Duration: 6-8 weeks
Off Period: Not listed
Protocol Notes
•
SubQ: 25-100mcg per injection up to twice per day.
•
Intranasal: 200-600mcg per day split into 2-3 doses.
•
Specific cycling guidance was absent from publications.
•
Recommend reassessing every 8 weeks and taking periodic breaks out of caution.
•
May use continuously under medical supervision.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.